rs45576136
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_000528.4(MAN2B1):c.844C>T(p.Pro282Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00365 in 1,613,946 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000528.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAN2B1 | NM_000528.4 | c.844C>T | p.Pro282Ser | missense_variant | 6/24 | ENST00000456935.7 | NP_000519.2 | |
MAN2B1 | NM_001173498.2 | c.844C>T | p.Pro282Ser | missense_variant | 6/24 | NP_001166969.1 | ||
MAN2B1 | XM_005259913.3 | c.844C>T | p.Pro282Ser | missense_variant | 6/24 | XP_005259970.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAN2B1 | ENST00000456935.7 | c.844C>T | p.Pro282Ser | missense_variant | 6/24 | 1 | NM_000528.4 | ENSP00000395473 | A1 | |
MAN2B1 | ENST00000221363.8 | c.844C>T | p.Pro282Ser | missense_variant | 6/24 | 1 | ENSP00000221363 | P4 | ||
MAN2B1 | ENST00000462144.1 | n.37C>T | non_coding_transcript_exon_variant | 1/2 | 3 | |||||
MAN2B1 | ENST00000466794.5 | n.826C>T | non_coding_transcript_exon_variant | 6/22 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00281 AC: 427AN: 152012Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.00260 AC: 653AN: 251474Hom.: 1 AF XY: 0.00265 AC XY: 360AN XY: 135920
GnomAD4 exome AF: 0.00374 AC: 5460AN: 1461816Hom.: 15 Cov.: 31 AF XY: 0.00360 AC XY: 2619AN XY: 727202
GnomAD4 genome AF: 0.00281 AC: 427AN: 152130Hom.: 1 Cov.: 32 AF XY: 0.00278 AC XY: 207AN XY: 74356
ClinVar
Submissions by phenotype
not provided Benign:4
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | May 17, 2017 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | MAN2B1: BS2 - |
Deficiency of alpha-mannosidase Uncertain:1Benign:2
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jul 26, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
MAN2B1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 18, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at